Journals / Türk Kardiyoloji Derneği Arşivi / 2017 / Cilt: 45 - Sayı: 6

The association between apelin gene polymorphism and coronary artery disease in young patients with acute obstructive coronary syndrome

Genç akut koroner sendromlu hastalarda apelin gen polimorfizminin tıkayıcı koroner arter hastalığı ile ilişkisi

Pages
520–526
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Univariate and multivariate logistic regression analysis revealed that the GG genotype of V103V was an independent predictor for the presence of critical CAD (odds ratio: 2.397; 95% confidence interval, 1.174-4.892; p=0.016).Conclusion: In cases of V103V polymorphism of the APLN gene, patients with the GG genotype were at a greater risk for the presence of atherosclerotic critical lesions compared with the control group.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The purpose of this study was to evaluate the association between V103V, 6140AG, TGA-Stop-TAA Stop, and 6016CA polymorphisms of the apelin (APLN) gene detected for the first time among young patients with acute coronary syndrome (ACS) and coronary artery disease (CAD).Methods: This was a prospective cross-sectional study.
📊
Key Findings & Data:The study population was divided into 2 groups.
💡
Conclusion & Impact:Univariate and multivariate logistic regression analysis revealed that the GG genotype of V103V was an independent predictor for the presence of critical CAD (odds ratio: 2.397; 95% confidence interval, 1.174-4.892; p=0.016).Conclusion: In cases of V103V polymorphism of the APLN gene, patients with the GG genotype were at a greater risk for the presence of atherosclerotic critical lesions compared with the control group.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The purpose of this study was to evaluate the association between V103V, 6140AG, TGA-Stop-TAA Stop, and 6016CA polymorphisms of the apelin (APLN) gene detected for the first time among young patients with acute coronary syndrome (ACS) and coronary artery disease (CAD).Methods: This was a prospective cross-sectional study. The study population was divided into 2 groups. The first group included 132 patients who were found to have critical lesions in their coronary arteries, while the control group consisted of 41 patients who were found to have normal coronary arteries or non-critical atherosclerotic lesions.Results: Among the gene polymorphisms, V103V was found to be more common in the critical CAD patients with the GG genotype compared with the control group (67.4% vs. 46.3%). On the other hand, the GT genotype was more common in the control group (53.7% vs. 32.6%). Univariate and multivariate logistic regression analysis revealed that the GG genotype of V103V was an independent predictor for the presence of critical CAD (odds ratio: 2.397; 95% confidence interval, 1.174-4.892; p=0.016).Conclusion: In cases of V103V polymorphism of the APLN gene, patients with the GG genotype were at a greater risk for the presence of atherosclerotic critical lesions compared with the control group.

Özet

Amaç: Biz bu çalışmayla genç akut koroner sendromlu (AKS) olgularda apelin (APLN) geninin ilk defa tespit edilen V103V, 6140AG, TGA-Stop-TAA Stop ve 6016CA polimorfizmlerinin kritik koroner arter hastalığı (KAH) varlığı ile ilişkisini değerlendirmeyi amaçladık.Yöntemler: Bu çalışma ileriye dönük kesitsel bir çalışmadır. Çalışmaya alınan olgular iki gruba ayrıldı. Birinci grubu koroner arterlerinde kritik lezyon saptanan 132 hasta oluşturdu. Kontrol grubunu ise koroner arterleri normal veya kritik olmayan aterosklerotik lezyon saptanan 41 olgu oluşturdu.Bulgular: Gen polimorfizmlerinden V103V'nin GG genotipi kritik KAH'lı hastalarda kontrol grubuna göre daha sık rastlandı (%67.4 ve %46.3). Buna karşın GT genotipi kontrol grubunda daha sıktı (%53.7 ve %32.6). Tek ve çok değişkenli lojistik regresyon analizinde, V103V'nin GG genotipinin kritik KAH varlığı için bağımsız öngördürücü olduğu saptandı (odds oranı: 2.397; %95 Güven Aralığı 1.174-4.892; p=0.016).Sonuç: Apelin geni V103V polimorfizminde GG genotipine sahip hastalar aterosklerotik kritik lezyon varlığı yönünden kontrol grubuna göre yüksek risk altındadır.

🔖

Cite This Article

ŞAŞMAZ, M. İ., GÜVEN, R., ARI, A., AKYOL, K. C., KEŞAPLI, M., ARSLAN, Ş., BAYAR, N. (2022). The association between apelin gene polymorphism and coronary artery disease in young patients with acute obstructive coronary syndrome. Türk Kardiyoloji Derneği Arşivi, Cilt: 45 - Sayı: 6, 520–526. https://ajindex.com/articles/632535

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. WHO. Global status report on noncommunicable diseases 2010. Available at: http://www.who.int/nmh/publications/ ncd_profiles_report.pdf. Accessed Nov, 2015
  2. TÜİK. Causes Of Death Statistics 2014. Available at: http:// www.tuik.gov.tr/PreHaberBultenleri.do?id=18855. Accessed Nov, 2015
  3. Kumar A, Cannon CP. Acute coronary syndromes: diagnosis and management, part I. Mayo Clin Proc 2009;84:917-38
  4. Mandelzweig L, Battler A, Boyko V, Bueno H, Danchin N, Filippatos G, et al; Euro Heart Survey Investigators. The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J 2006;27:2285-93
  5. Jha AK, Li Z, Orav EJ, Epstein AM. Care in U.S. hospitals--the Hospital Quality Alliance program. N Engl J Med 2005;353:265-74
  6. Schoenenberger AW, Radovanovic D, Stauffer JC, Windecker S, Urban P, Niedermaier G, et al; AMIS Plus Investigators. Acute coronary syndromes in young patients: presentation, treatment and outcome. Int J Cardiol 2011;148:300-4
  7. Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 1988;60:299-308 8. Lee DK, Cheng R, Nguyen T, Fan T, Kariyawasam AP, Liu Y, et al. Characterization of apelin, the ligand for the APJ receptor. J Neurochem 2000;74:34-41
  8. Medhurst AD, Jennings CA, Robbins MJ, Davis RP, Ellis C, Winborn KY, et al. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J Neurochem 2003;84:1162-72
  9. Kleinz MJ, Davenport AP. Emerging roles of apelin in biology and medicine. Pharmacol Ther 2005;107:198-211
  10. Pitkin SL, Maguire JJ, Kuc RE, Davenport AP. Modulation of the apelin/APJ system in heart failure and atherosclerosis in man. Br J Pharmacol 2010;160:1785-95
  11. Jin W, Su X, Xu M, Liu Y, Shi J, Lu L, et al. Interactive association of five candidate polymorphisms in Apelin/APJ pathway with coronary artery disease among Chinese hypertensive patients. PLoS One 2012;7:e51123
  12. Falcone C, Bozzini S, Schirinzi S, Buzzi MP, Boiocchi C, Totaro R, et al. APJ polymorphisms in coronary artery disease patients with and without hypertension. Mol Med Rep 2012;5:321-5
  13. Chen MM, Ashley EA, Deng DX, Tsalenko A, Deng A, Tabibiazar R, et al. Novel role for the potent endogenous inotrope apelin in human